Shanghai Pharmaceuticals (02607) Releases Extraordinary General Meeting Notice

Bulletin Express
11/18

Shanghai Pharmaceuticals (02607) has announced that its Extraordinary General Meeting will be held on December 9, 2025, at 14:00. The venue is the Meeting Room on the second floor of Shanghai Pharma Building, No. 200 Taicang Road, Huangpu District, Shanghai, the People’s Republic of China.

Holders of H shares who wish to attend the meeting (in person or by proxy) should complete the reply slip, providing the shareholder’s name, address, and the number of H shares registered in their name. Completed reply slips must be delivered to Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, on or before November 28, 2025, either in person or by mail.

For shareholders intending to vote at the meeting, it is required that all transfer documents, along with the relevant share certificates, are lodged with the same registrar no later than 16:30 on December 3, 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10